News

FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development and manufacturing facility in Madison, Wisconsin, significantly…
Read More...

Eli Lilly and Company reported positive topline results from its Phase 3 TRIUMPH-1 clinical trial, showing that investigational obesity treatment retatrutide delivered substantial and…
Read More...

Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis GmbH, strengthening its oncology pipeline with next-generation…
Read More...

Gilead Sciences has renewed its collaboration with the World Health Organization (WHO) for another five years, strengthening efforts to eliminate visceral leishmaniasis (VL), commonly…
Read More...

Johnson & Johnson has partnered with the Department of Health – Abu Dhabi to launch a global initiative aimed at building an open surgical intelligence network, positioning Abu…
Read More...

Regeneron Pharmaceuticals reported encouraging early-stage results from a Phase 1/2 clinical trial evaluating Lynozyfic (linvoseltamab) in patients with relapsed or treatment-resistant…
Read More...

Eli Lilly and Company has acquired preclinical biotechnology company Engage Biologics Inc. in a deal worth up to $202 million, strengthening the drugmaker’s ambitions in next-generation…
Read More...

SERB Pharmaceuticals and Hansa Biopharma have entered into an agreement under which SERB will acquire exclusive development and commercialization rights to Idefirix (imlifidase) across…
Read More...

QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...

Global pharmaceutical company Merck & Co. has announced positive pivotal Phase 3 results for sacituzumab tirumotecan (sac-TMT), an investigational TROP2-directed antibody-drug…
Read More...

Takeda Pharmaceutical Company said a U.S. federal jury has returned a verdict against the company in long-running antitrust litigation involving constipation drug AMITIZA, awarding…
Read More...

Regeneron Pharmaceuticals has entered into a strategic research collaboration with Parabilis Medicines to discover and develop a new class of therapeutics designed to target…
Read More...

VERTANICAL said the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to VER-01, the company’s investigational non-opioid treatment for chronic low back…
Read More...

Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence agents designed to support biopharmaceutical decision-making and…
Read More...

AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative treatment with Imfinzi combined with neoadjuvant enfortumab vedotin…
Read More...

Arna Pharma Inc. and Slate Run Pharmaceuticals have officially finalized a joint venture aimed at creating a larger U.S.-based specialty pharmaceutical company focused on branded…
Read More...

Bristol Myers Squibb and Hengrui Pharma have entered into a broad strategic collaboration and licensing agreement focused on developing innovative medicines across oncology, hematology,…
Read More...

Pfizer Inc. announced that the European Commission has approved an expanded indication for HYMPAVZI, allowing its use in patients aged 12 years and older with hemophilia A or hemophilia…
Read More...

Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced updated clinical data from the frontline arm of the Phase 1 KOMET-007 trial evaluating Ziftomenib in combination with intensive…
Read More...

Assertio Holdings, Inc. announced that its Board of Directors has approved a definitive agreement for Zydus Lifesciences Limited, through its subsidiary Zydus Worldwide DMCC, to acquire…
Read More...